Corteva, Inc. (CTVA) · Oct 7, 2026 · New debt
$1.44B debt exchange — 89.9% of $1.60B accepted; $161.4M remains outstanding
Corteva’s debt exchange is complete: Vylor takes on replacement notes while 90% of three EIDP bond series are retired ahead of the separation.
Corteva is executing its planned split into two public companies: crop protection remains with New Corteva, while Vylor becomes the future seed and genetics company. This filing is the financing mechanics of that separation, not a change to the operating businesses.
The exchange largely completed the debt migration. Vylor accepted $1.439 billion of EIDP notes across three series, equal to roughly 90% of the $1.600 billion originally outstanding; only $161.4 million remains with EIDP after settlement. Such accepted notes were retired and canceled. 〔0〕
| EIDP note series | Tendered | Accepted | Remaining after settlement |
|---|---|---|---|
| 2.300% senior notes due 2030 | $434.841M | $434.839M | $65.161M |
| 5.125% senior notes due 2032 | $476.214M | $476.214M | $23.786M |
| 4.800% senior notes due 2033 | $527.584M | $527.584M | $72.416M |
| Total | $1.439B | $1.439B | $161.363M |
This is execution, not a surprise. The exchange offers, consent solicitations, required amendments, and expected October 1 settlement had already been announced; the new information is the final participation level and the fact that the amendments are now operative. 〔1〕
The practical effect is cleaner separation readiness. Debt associated with the exchanged notes moves into Vylor’s replacement-note structure, while the accepted EIDP notes disappear and cannot be reissued. That reduces a separation-related financing uncertainty, but the filing does not disclose a new operating outlook, profitability change, or incremental value creation.
Bottom line: Corteva completed a largely expected debt reallocation that materially advances the legal and capital-structure work needed for the split. It matters operationally, but it is confirmation of the separation plan rather than a fresh business catalyst.
A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.
A buy-side analyst on every ticker — the whole market decoded the second it moves, before it's a headline. Free gives you a taste. Pro takes the cap off and opens the full read on every company.
by Signing in NOW, claim your FREE 14-day Pro trial!